Inflammatory responses, initiated by the invasion of pathogens or by tissue injury caused by free radicals, are a series of vascular and cellular reactions. Some important chemical mediators of inflammation are interleukin (IL)-1, -6, -12, and tumor necrosis factor-α, prostaglandins, etc… IL-6 has pro-and anti-inflammatory properties. IL-6 is involved not only in the activation of the immune system but also in regenerative process as well as in the regulation of metabolism. 1 The IL-12 family of cytokines is key players in the regulation of T cell responses. IL-12 has both early proinflammatory and late anti-inflammatory effects.
2 In addition to these, TNF-α is a well-characterized pro-inflammatory cytokine released primarily from monocytes and macrophages upon invasion of the host by a wide variety of pathogens. It plays a crucial role in host defense and in the inflammatory response. Although it has numerous beneficial roles in immune regulation, it has also been implicated in the pathogenesis of both acute and chronic inflammatory disease.
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Since ancient times, traditional medicines and phytopharmaceuticals have been used for the treatment of inflammatory and other disorders. Natural products offer great hope in the identification of bioactive compounds and their development into drugs for the treatments of inflammatory diseases. One of the well-known drugs, aspirin was discovered based on the known analgesic and antipyretic properties of the bark of willow-tree since 400 BC. 4 Recently, we have focused on a number of medicinal plants with antiinflammatory activities and found some of them to possess the anti-inflammatory active compounds such as Acanthopanax koreanum 5 and Hedychium coronarium.
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Eleutherine bulbosa (Miller) Urb. is an herbal medicinal plant from Iridaceae family. This plant is used in oriental medicine for the treatment of diseases such as heart failure, cancer, intestinal disorders, skin disease, and infertility. In the course of screening of medicinal plants for antiinflammatory activities, we found the methanol extract of the rhizome of E. bulbosa potently inhibit the lipopolysaccharide (LPS)-stimulated productions of IL-12 p40 and IL-6 cytokines in bone marrow-derived dendritic cells (DCs) with IC 50 values of 0.1 ± 0.05 and 16.2 ± 0.3 μg/mL, respectively (Table 2) . SB203580, an inhibitor of cytokine suppressive binding protein/p38 kinase, was used as a positive control. SB203580 inhibited IL-12 p40 and IL-6 production with IC 50 values of 2.5 ± 0.1 and 1.7 ± 0.2 μg/mL, respectively. The methanol extract of the E. bulbosa rhizome was then fractionated with chloroform, ethyl acetate, and water. From these fractions and using combined chromatographic separations, one new and fourteen known compounds were isolated.
Compound 15 of which were assigned to be a dihydronaphthopyrone moiety and the remaining 6 assigned to a monosaccharide moiety. The aglycone of 1 was concluded to be dihydroeleutherinol (1a). 10 The NMR data of 1 were similar to those of eleutherinoside A (3) 11 except for the disappearance of a double bond in the γ-pyrone ring. The HMBC correlations from H-2 (δ H 4.87) to C-1a (δ C 163.4), C-3 (δ C 45.9), C-4 (δ C 194.3), and 2-Me (δ C 20.7); from H-3 (δ H 2.57 and 2.62) to C-2 (δ C 78.0), C-4 (δ C 194.3), and 2-Me (δ C 20.7) (see Figure 2) suggested that the methyl and carbonyl groups were at C-2 and C-4 of the dihydropyrone ring, respectively. On the other hand, HMBC correlations between 5-Me (δ H 2.45) and C-4a (δ C 114.6), C-5 (δ C 137.6), and C-6 (δ C 124.2), between H-7 (δ H 6.67) and C-6 (δ C 124.2), C-8 (δ C 161.4), C-9 (δ C 103.5), and C-10a (δ C 109.9), between H-9 (δ H 6.45) and C-7 (δ C 103.6), C-8 (δ C 161.4), C-10 (δ C 158.7), and C-10a (δ C 109.9) were observed. These confirmed that one methyl and two hydroxyl groups were at C-5, C-8, and C-10, respectively. Acid hydrolysis of 1 revealed D-glucose and aglycone 1a. Moreover, the position of glucose at C-8 was confirmed by HMBC correlations between H-1' glc (δ H 4.93) and C-8 (δ C 161.4). The CD spectrum of 1 showed a negative Cotton effect around 319 nm (See Supporting Information), similarly to those of (2S)-5-hydroxy-6,8-dimethoxy-2-methyl-4H-2,3-dihydronaphtho[2,3-b]-pyran-4-one, 12 suggested the configuration at C-2 to be S. In addition, the aglycone 1a can be determined by comparing the optical rotation of 1a with those of series of 2-methylchroman-4-one as well as the optical rotation of (R) dihydroeleutherinol ( = +8.8).
13 So, the optical rotation of 1a ( = -38.3) suggested a stereochemistry at C-2 to be S by comparing the optical rotation of (S) 5,7-dihydroxy-2-methylchroman-4-one ( = -58.6)
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and (R) 7-methoxy-2-methylchroman-4-one ( = +53.2).
To the best our knowledge, aglycone 1a was with S configuration was reported for the first time. Consequently, the structure of 1 was determined to be (2S) dihydroeleutherinol-
The known compounds were characterized as eleutherinol (2) anthraquinone (15). 21 They were elucidated on the basis of spectral data and chemical evidence, which were in good agreement with those reported in the literature (see Figure 1) .
Continuing with our interest in the evaluation of the antiinflammatory plant and to search novel anti-inflammatory agent, we have evaluated the effects of compounds from E. bulbosa in the inflammatory response by bone marrowderived dendritic cells. We first used a colorimetric MTT assay to confirm that these compounds have no or little effect on the cell viability (data not shown). None of them exhibited cytotoxic activity. Upon LPS treatment, dendritic cells (DCs) are known to secrete pro-inflammatory cytokine, including IL-6, IL-12 p40, and TNF-α. In our experiments, dendritic cells were incubated in 48-well plates at a density of 2 × 10 5 cells/mL, and then treated for 1 h with the compounds at the concentration of 25 μM, and then stimulated with LPS (10 ng/mL) (see Figure 3) . 22 One new, 1, and three known compounds, 4, 5, and 6 showed potent inhibitory activities at the concentration of 25 μM. All these active compounds were chosen for further tested at the concentrations of 6.3 to 50.0 μM (see Figure 4) . Positive control, SB203580, inhibited IL-12 p40, IL-6, and TNF-α production with IC 50 values of 5.2 ± 0.1, 3.5 ± 0.1, and 7.5 ± 0.2 µM, respectively (Table 2) . Of these compounds, compounds 1, 4, 5, and 6 inhibited potent activity of LPS-stimulated IL-12 p40 production reducing the levels of this cytokine with IC 50 values ranging from 0.1 ± 0.08 to 5.0 ± 0.4 μM. Compounds 1, 5, and 6 also showed the potent inhibitory activity on the IL-6 production with IC 50 values ranging from 1.7 ± 0.1 to 5.0 ± 0.2 μM. However, only two compounds 4 and 5 exhibited moderate inhibitory activity on the TNF-α production with IC 50 values of 61.2 ± 1.5 and 39.6 ± 2.0 μM. (-)-Hongconin (4), eleutherin (5) , and isoeleutherin (6) isolated from Eleutherine americana also exhibited potent inhibitory activity on nitric oxide production LPS-activated mouse RAW 264.7 macrophage cell-line. 13 To the best our knowledge, this is the first report on anti-inflammatory activities of E. bulbosa and its chemical components. Collectively, a new compound 1 as well as three known compounds, 4, 5 Supporting Information. General procedures, extraction, isolation, hydrolysis procedure, cell culture and measurement of cytokine production assays, and NMR and CD spectra of 1 and 1a are available as Supporting Information.
